# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-21-019915
Filing Date
2021-10-08
Accepted
2021-10-08 17:13:58
Documents
31
Period of Report
2021-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20211007.htm iXBRL | 8-K | 39835
2 | EX-4.1 | ex41_supplementalindentu.htm | EX-4.1 | 14921
3 | EX-10.1 | ex101_consentfeeletterfo.htm | EX-10.1 | 18845
7 | GRAPHIC | ex101_consentfeeletterfo001.jpg | GRAPHIC | 281600
8 | GRAPHIC | ex101_consentfeeletterfo002.jpg | GRAPHIC | 283807
9 | GRAPHIC | ex101_consentfeeletterfo003.jpg | GRAPHIC | 244472
10 | GRAPHIC | ex101_consentfeeletterfo004.jpg | GRAPHIC | 42307
11 | GRAPHIC | ex101_consentfeeletterfo005.jpg | GRAPHIC | 47682
12 | GRAPHIC | ex101_consentfeeletterfo006.jpg | GRAPHIC | 53120
13 | GRAPHIC | ex101_consentfeeletterfo007.jpg | GRAPHIC | 36006
14 | GRAPHIC | ex101_consentfeeletterfo008.jpg | GRAPHIC | 35551
15 | GRAPHIC | ex101_consentfeeletterfo009.jpg | GRAPHIC | 36136
16 | GRAPHIC | ex101_consentfeeletterfo010.jpg | GRAPHIC | 34367
17 | GRAPHIC | ex101_consentfeeletterfo011.jpg | GRAPHIC | 113027
18 | GRAPHIC | ex41_supplementalindentu001.jpg | GRAPHIC | 220711
19 | GRAPHIC | ex41_supplementalindentu002.jpg | GRAPHIC | 235449
20 | GRAPHIC | ex41_supplementalindentu003.jpg | GRAPHIC | 223058
21 | GRAPHIC | ex41_supplementalindentu004.jpg | GRAPHIC | 216989
22 | GRAPHIC | ex41_supplementalindentu005.jpg | GRAPHIC | 48895
23 | GRAPHIC | ex41_supplementalindentu006.jpg | GRAPHIC | 50633
| Complete submission text file | 0001628280-21-019915.txt |  | 3264353

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20211007.xsd | EX-101.SCH | 1905
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20211007_lab.xml | EX-101.LAB | 24975
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20211007_pre.xml | EX-101.PRE | 13181
24 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20211007_htm.xml | XML | 11260

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211316024
SIC: 2834 Pharmaceutical Preparations